Full Press Release Details
BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company navigating new territory in patient-directed cancer treatment, today announced that management will participate in several virtual investor conferences in November 2021.
Details are as follows:
Conference: BMO Biopharma Spotlight Series: Emerging Trends and Therapeutics in Oncology
Panel; Emerging Trends in Oncology: Targeted Therapies and Other Novel Treatment Modalities
Date: Monday, November 8, 2021, 3:25pm EST; available for replay following the event
Conference: Credit Suisse 30th Annual Healthcare Conference
Fireside Chat; Investor Meetings
Date: Thursday, November 11, 2021, 3:30pm EST; live and available for replay
Conference: Stifel 2021 Virtual Healthcare Conference
Corporate Presentation; Investor Meetings
Date: Monday, November 15, 2021, 11:20am EST; live and available for replay
Conference: Jefferies London Healthcare Conference
Corporate Presentation; Investor Meetings
Date: Thursday, November 18, 2021, 8:00am GMT; pre-recorded and available for replay
The presentation webcasts can be accessed by visiting the Investors & Media section of the company’s website at www.ikenaoncology.com. The webcast will be archived for a period of 90 days following the conclusion of the live event.
About Ikena Oncology
LifeSci Communications